St. Jude Medical gets tangled in its own rope over Riata
April 13, 2012 by MassDevice staff
St. Jude Medical's pugilistic response to a study linking its recalled Riata defibrillator leads with 22 deaths is proving to be counter-productive, as doctors and investors shy away from its next-generation Durata lead.
The medical device world was abuzz this week as St. Jude Medical (NYSE:STJ) came out swinging against critics of its recalled Riata defibrillator lead.
The St. Paul, Minn.-based company's vociferous response reportedly has doctors and investors backing away from St. Jude, according to Reuters, and has taken some 13.4% from STJ's shares since late March.
- Show full page
- Login to post comments
-
Permalink
RECENT BLOG POSTS
- A day in the life: A pediatric neurosurgeon's vision
- Medical Device Tax: Are Conservatives' goals hampering repeal efforts?
- Personal health record use by adolescents
- Can Johnson & Johnson fire on all cylinders again?
- U.S. FDA to require proof of IEC 60601-1 3rd Edition in summer 2013
- A cure for coffee breath?
- A Goldilocks approach to leaky blood vessels: Not too stiff, but not too loose
- Optimizing electronic medication administration records
- A bold new vision for Meditech
- Medtech storytelling in the era of comparative effectiveness
Navigation
NEWS
Covidien touts positive study data from Barrx ablation system
Covidien champions positive results for the Barrett's esophagus ablation device it acquired along...
Abbott touts CE Mark for "world's longest" coronary DES
Illinois healthcare giant Abbott lands European regulatory approval for the Xience Xpedition 48,...
ALung pursues Chinese approval for Hemolung
ALung Technologies says it's going for a Chinese regulatory nod for its Hemolung respiratory assist...
Legal: Patient's lawyer says Intuitive Surgical's training is all about "control"
An attorney for a plaintiff suing robot-assisted surgical systems maker Intuitive Surgical says the...
Can a smartphone help spot a stroke? | MassDevice.com On Call
The American Stroke Assn. and partners release the Spot a Stroke F.A.S.T. smartphone app to help...
